19
Participants
Start Date
June 9, 2021
Primary Completion Date
August 31, 2023
Study Completion Date
November 30, 2023
AST-021p
3 priming immunization (2weeks x3) in 4 cohort groups (1.2mg, 2.4mg, 3.6mg and 4.8mg AST-021p) if possible, 3 boosting immunization (4weeks x 3) in cohort groups after priming immunization
Korea University Anam Hospital, Seoul
Korea University Guro Hospital, Seoul
Seoul ST. Mary's Hospital, Seoul
Lead Sponsor
Aston Sci. Inc.
INDUSTRY